methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate

C40H47F3N8O6 — CID 126605784

IUPACmethyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate
SMILESCOC(=O)NCC(=O)N1CCCC1c1ncc(-c2ccc(-c3ccc(NC(=O)N4CC5CCC(C4)N5C4CCN(C(=O)C5CC5)CC4)cc3OC(F)(F)F)cc2)[nH]1
InChIInChI=1S/C40H47F3N8O6/c1-56-39(55)45-21-35(52)50-16-2-3-33(50)36-44-20-32(47-36)25-6-4-24(5-7-25)31-13-10-27(19-34(31)57-40(41,42)43)46-38(54)49-22-29-11-12-30(23-49)51(29)28-14-17-48(18-15-28)37(53)26-8-9-26/h4-7,10,13,19-20,26,28-30,33H,2-3,8-9,11-12,14-18,21-23H2,1H3,(H,44,47)(H,45,55)(H,46,54)
InChIKeyRTOYKDGDLVUDBL-UHFFFAOYSA-N
MW792.86 g/mol
LogP5.74
Rot. Bonds9

About methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate

methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate (PubChem CID 126605784) has the molecular formula C40H47F3N8O6 and a molecular weight of 792.86 g/mol. Its IUPAC name is methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate.

Molecular Properties

Compound Namemethyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate
PubChem CID126605784
Molecular FormulaC40H47F3N8O6
Molecular Weight792.86 g/mol
Exact Mass792.36
IUPAC Namemethyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate
SMILESCOC(=O)NCC(=O)N1CCCC1c1ncc(-c2ccc(-c3ccc(NC(=O)N4CC5CCC(C4)N5C4CCN(C(=O)C5CC5)CC4)cc3OC(F)(F)F)cc2)[nH]1
InChIInChI=1S/C40H47F3N8O6/c1-56-39(55)45-21-35(52)50-16-2-3-33(50)36-44-20-32(47-36)25-6-4-24(5-7-25)31-13-10-27(19-34(31)57-40(41,42)43)46-38(54)49-22-29-11-12-30(23-49)51(29)28-14-17-48(18-15-28)37(53)26-8-9-26/h4-7,10,13,19-20,26,28-30,33H,2-3,8-9,11-12,14-18,21-23H2,1H3,(H,44,47)(H,45,55)(H,46,54)
InChIKeyRTOYKDGDLVUDBL-UHFFFAOYSA-N
XLogP5.74
TPSA152.44 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds9
Heavy Atoms57
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500792.86
LogP ≤ 55.74
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Analyze methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate?
The IUPAC name of methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate (CID 126605784) is methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate.
What is the SMILES notation for methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate?
The canonical SMILES for methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate is COC(=O)NCC(=O)N1CCCC1c1ncc(-c2ccc(-c3ccc(NC(=O)N4CC5CCC(C4)N5C4CCN(C(=O)C5CC5)CC4)cc3OC(F)(F)F)cc2)[nH]1.
What is the InChIKey of methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate?
The InChIKey is RTOYKDGDLVUDBL-UHFFFAOYSA-N. The full InChI is InChI=1S/C40H47F3N8O6/c1-56-39(55)45-21-35(52)50-16-2-3-33(50)36-44-20-32(47-36)25-6-4-24(5-7-25)31-13-10-27(19-34(31)57-40(41,42)43)46-38(54)49-22-29-11-12-30(23-49)51(29)28-14-17-48(18-15-28)37(53)26-8-9-26/h4-7,10,13,19-20,26,28-30,33H,2-3,8-9,11-12,14-18,21-23H2,1H3,(H,44,47)(H,45,55)(H,46,54).
What are the key properties of methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate?
methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate has a molecular weight of 792.86 g/mol, XLogP of 5.74, 9 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for methyl N-[2-[2-[5-[4-[4-[[8-[1-(cyclopropanecarbonyl)piperidin-4-yl]-3,8-diazabicyclo[3.2.1]octane-3-carbonyl]amino]-2-(trifluoromethoxy)phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]carbamate is sourced from PubChem (CID 126605784), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).